The TB GOLD Test is an advanced diagnostic tool that uses an interferon-gamma release assay (IGRA) to detect latent tuberculosis infection.

Unlike the tuberculin skin test (TST), the TB GOLD Test does not require a return visit for reading and provides more accurate results by measuring the immune response to TB-specific antigens.

No special preparation is required. You can eat and drink normally before the test, but inform your healthcare provider about any medications or recent illnesses.

Results are typically available within 2 to 7 days after the sample is analyzed in the laboratory.

The TB GOLD Test helps accurately diagnose latent TB infection, which is crucial for preventing the progression to active TB and ensuring appropriate treatment and management.

Types include gastric bypass, gastric sleeve, adjustable gastric banding, and biliopancreatic diversion with duodenal switch.

ICU Bedside Dialysis is a service provided in the Intensive Care Unit (ICU) for patients with kidney failure who require dialysis while remaining in the ICU for critical care.

Patients may need bedside dialysis if they have acute kidney injury or chronic kidney disease that requires dialysis while they are critically ill or unstable.

Bedside dialysis is performed using specialized equipment and techniques to remove waste products and excess fluids from the blood while the patient remains in the ICU.

Bedside dialysis allows for continuous monitoring and treatment of critically ill patients without needing to transport them to a separate dialysis unit, which can be safer and more convenient.

Risks include infection, bleeding, and complications related to the dialysis procedure. The ICU team closely monitors patients to manage and minimize these risks.